Remdesivir has questionable efficacy in patients with severe COVID-19 receiving high-flow oxygen

Clinical Research In Practice: The Journal of Team Hippocrates Pub Date : 2021-10-13 DOI:10.22237/crp/1625097660

Gabriel B. Burdick

引用次数: 0

Abstract

A clinical decision report using: Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the Treatment of Covid-19 — Final Report. N Engl J Med. 2020;383:1813-1826. https://doi.org/10.1056/NEJMoa2007764 for a patient with severe COVID-19.

查看原文本刊更多论文

Remdesivir对接受高流量氧气治疗的重症COVID-19患者的疗效值得怀疑

临床决策报告使用:Beigel JH, Tomashek KM, Dodd LE等。瑞德西韦治疗Covid-19的最终报告。中华医学杂志，2010;33(3):326 - 326。对于患有严重COVID-19的患者https://doi.org/10.1056/NEJMoa2007764。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Research In Practice: The Journal of Team Hippocrates

自引率

0.00%

发文量